Dashboard
Manage Tickers

MRKMerck & Co., Inc.

NYSE merck.com


$ 116.61 $ 0.52 (0.45 %)    

Thursday, 22-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 475.46 $ -7.65 (-1.59 %)
DIA $ 407.51 $ -1.51 (-0.37 %)
SPY $ 556.52 $ -4.40 (-0.78 %)
TLT $ 97.74 $ -0.98 (-0.99 %)
GLD $ 229.39 $ -2.78 (-1.2 %)
$ 116.55
$ 116.14
$ 116.58 x 100
$ 116.63 x 100
$ 115.23 - $ 116.72
$ 97.23 - $ 134.63
8,201,177
na
295.43B
$ 0.34
$ 21.51
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2024 06-30-2024 10-Q
2 05-03-2024 03-31-2024 10-Q
3 02-26-2024 12-31-2023 10-K
4 11-03-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-05-2023 03-31-2023 10-Q
7 02-24-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 02-25-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-05-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-06-2020 03-31-2020 10-Q
19 02-26-2020 12-31-2019 10-K
20 11-05-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 02-27-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-08-2018 03-31-2018 10-Q
27 02-27-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 02-28-2017 12-31-2016 10-K
32 11-07-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-09-2016 03-31-2016 10-Q
35 02-26-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-06-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-10-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mercks-ebola-vaccine-showed-84-effectiveness-during-large-outbreak-in-africa
Merck's Ebola Vaccine Showed 84% Effective...
08/22/2024 13:40:29

Merck's rVSV-ZEBOV vaccine, the only WHO-prequalified vaccine for Ebola outbreaks caused by the Zaire ebolavirus, is FDA-ap...

health-canada-approves-mercks-keytruda-in-combination-with-enfortumab-vedotin-for-adult-patients-with-unresectable-locally-advanced-or-metastatic-urothelial-cancer-with-no-prior-systemic-therapy
Health Canada Approves Merck's Keytruda In...
08/22/2024 11:10:52

merck--cos-options-a-look-at-what-the-big-money-is-thinking
Merck & Co's Options: A Look at What the B...
08/19/2024 20:00:32

biden-administration-targets-6b-savings-through-medicare-drug-price-negotiations
Biden Administration Targets $6B Savings T...
08/15/2024 14:38:21

Medicare drug price negotiations, enabled by the Inflation Reduction Act, are set to save the U.S. government $6 billion.

in-depth-analysis-merck-amp-co-versus-competitors-in-pharmaceuticals-industry
In-Depth Analysis: Merck & Co Versus C...
08/14/2024 15:00:39

9-health-care-stocks-whale-activity-in-todays-session
9 Health Care Stocks Whale Activity In Tod...
08/13/2024 17:35:23

mercks-13b-deal-for-potential-autoimmune-disorder-candidate-is-relevant-to-cullinans-investigational-drug-says-analyst
Merck's $1.3B Deal For Potential Autoimmun...
08/09/2024 19:18:10

Merck has agreed to acquire CN201, a bispecific antibody from Curon Biopharmaceutical, for $700 million. This acquisition aims ...

im-not-proud-of-myself-jim-cramer-says-he-bought-worst-of-the-three-ge-stocks
'I'm Not Proud Of Myself': Jim Cramer Says...
08/09/2024 12:01:01

Jim Cramer recommends buying Merck (MRK) due to faith in CEO Robert Davis. He advises against Teladoc (TDOC) due to Cathie Wood...

merck-has-agreed-to-acquire-cn201-an-investigational-clinical-stage-bispecific-antibody-for-b-cell-associated-diseases-from-a-privately-held-curon-biopharmaceutical-for-an-upfront-payment-of-700m-in-cash-and-up-to-600m-in-milestone-payments
Merck Has Agreed To Acquire CN201, An Inve...
08/09/2024 10:48:40

CN201 is currently being evaluated in Phase 1 and Phase 1b/2 clinical trials for the treatment of patients with relapsed or ref...

merck-stops-lung-cancer-study-for-keytruda-combo-due-to-ineffective-results-side-effects
Merck Stops Lung Cancer Study For Keytruda...
08/08/2024 15:51:24

Merck discontinues the Phase 3 KeyVibe-008 trial for the fixed-dose combination of vibostolimab and Keytruda in extensive-stage...

looking-into-merck--cos-recent-short-interest
Looking Into Merck & Co's Recent Short Int...
08/08/2024 15:30:19

merck-reports-discontinuation-of-phase-3-keyvibe-008-trial-based-on-recommendation-of-an-independent-data-monitoring-committee
Merck Reports Discontinuation Of Phase 3 K...
08/08/2024 10:47:10

At a pre-planned analysis, data showed that the primary endpoint of overall survival (OS) met the pre-specified futility criter...

Core News & Articles
Daiichi Sankyo, Merck Expand Partnership T...
08/06/2024 10:50:34

Agreement builds on and complements Daiichi Sankyo and Merck's shared commitment to develop novel medicines for patients ...

bristol-myers-squibb-terminates-cancer-drug-development-program-with-agenus
Bristol Myers Squibb Terminates Cancer Dru...
08/05/2024 18:31:11

Agenus reports that Bristol Myers Squibb (NYSE: BMY) is ending their 2021 agreement, returning the TIGIT bispecific antibody AG...

small-cap-cancer-focused-nuvation-bio-pulls-plug-on-early-stage-program-after-considering-phase-1-solid-tumor-data
Small-Cap Cancer-Focused Nuvation Bio Pull...
08/05/2024 18:27:54

Nuvation Bio halts its NUV-868 BET inhibitor program after Phase 1 study analysis. The decision impacts solid tumor treatments ...

mercks-blockbuster-vaccine-gardasil-sales-in-china-analyst-highlights-challenges-and-opportunities
Merck's Blockbuster Vaccine Gardasil Sales...
08/05/2024 18:25:07

Goldman Sachs discusses Gardasil's performance in China with Merck's Joe Romanelli. Gardasil faces challenges due to ma...

behind-the-scenes-of-merck--cos-latest-options-trends
Behind the Scenes of Merck & Co's Latest O...
08/05/2024 16:31:26

microstrategy-intel-and-moderna-are-among-top-12-large-cap-losers-last-week-july-28-august-3-are-the-others-in-your-portfolio
MicroStrategy, Intel And Moderna Are Among...
08/04/2024 15:20:40

12 worst-performing large-cap stocks in the last week. Symbotic, Intel, Snap, Moderna, Mobileye, Pinterest, Arm, Entegris, Atla...

moderna-stock-trading-lower-on-dismal-guidance-analysts-cuts-price-targets-noting-competitive-pressure-from-gsk-pfizer
Moderna Stock Trading Lower On Dismal Guid...
08/02/2024 18:22:50

Moderna cuts its 2024 sales forecast due to weaker demand for COVID-19 vaccines. Sales now expected between $3B-$3.5B, down fro...

cathie-woods-ark-adds-over-19m-worth-of-moderna-shares-after-thursdays-21-plunge-on-guidance-cut
Cathie Wood's Ark Adds Over $19M Worth Of ...
08/02/2024 13:00:13

Moderna's vaccine magic is slowly losing its charm, as evidenced by the warning the company issued on Thursday but Ark repo...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION